Higher Prevalence of Klebsiella pneumoniae Extended-Spectrum β-Lactamase in Patients on Renal Replacement Therapy

Journal of Korean Medical Science

Volumn 28, Issue 8, 2013, Pages 1187-1193

  Lee, Hyang Lim ^a   Whang, Dong Hee ^b   Park, Dong Won ^c   Lee, Young Jin ^b   Kim, Yeong Hoon ^d   Chin, Ho Jun ^e   Kim, Suhnggown ^e   Koo, Ho Seok ^c  

^a Seoul Bukbu Geriatric Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c MH Yeonse Hospital   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e Seoul National University Hospital   (South Korea)

Author keywords

Dialysis; Extended spectrum lactamase; Klebsiella pneumoniae

Indexed keywords

BETA LACTAMASE; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; DIALYSIS; ENZYMOLOGY; EXTENDED-SPECTRUM Β-LACTAMASE; FEMALE; HUMAN; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PNEUMONIA; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK; RISK FACTOR; VERY ELDERLY;

DIALYSIS; EXTENDED-SPECTRUM Β-LACTAMASE; KLEBSIELLA PNEUMONIAE;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN;

EID: 84884364550     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.8.1187     Document Type: Article

References (29)

1. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32: S94-103.
2. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 26-32.
3. Burwen DR, Banerjee SN, Gaynes RP. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis 1994; 170: 1622-5.
4. Itokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 1996; 23: 779-84.
5. Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006; 21: 816-22.
6. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med 2005; 352: 380-91.
7. Kang CI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, Lee NY, Song JH. Epidemiology and risk factors of community onset infections caused by extended-spectrum β- lactamase-producing Escherichia coli strains. J Clin Microbiol 2012; 50: 312-7.
8. Lee JA, Kang CI, Joo EJ, Ha YE, Kang SJ, Park SY, Chung DR, Peck KR, Ko KS, Lee NY, et al. Epidemiology and clinical features of communityonset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Microb Drug Resist 2011; 17: 267-73.
9. Park YS, Adams-Haduch JM, Shutt KA, Yarabinec DM 3rd, Johnson LE, Hingwe A, Lewis JS 2nd, Jorgensen JH, Doi Y. Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States. Antimicrob Agents Chemother 2012; 56: 1870-6.
10. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008; 3: 1526-33.
11. Fejfarová V, Jirkovská A, Petkov V, Boucek P, Skibová J. Comparison of microbial findings and resistance to antibiotics between transplant patients, patients on hemodialysis, and other patients with the diabetic foot. J Diabetes Complications 2004; 18: 108-12.
12. D'Agata E, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenover F. The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital. J Infect 1998; 36: 279-85.
13. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
14. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004; 17: 432-7.
15. Bailey KV, Ferro-Luzzi A. Use of body mass index of adults in assessing individual and community nutritional status. Bull World Health Organ 1995; 73: 673-80.
16. Chandra RK. Interactions of nutrition, infection and immune response: immunocompetence in nutritional deficiency, methodological considerations and intervention strategies. Acta Paediatr Scand 1979; 68: 137-44.
17. Merritt RJ, Kalsch M, Roux LD, Ashley-Mills J, Siegel SS. Significance of hypoalbuminemia in pediatric oncology patients: malnutrition or infection? JPEN J Parenter Enteral Nutr 1985; 9: 303-6.
18. Dahn MS, Jacobs LA, Smith S, Lange MP, Mitchell RA, Kirkpatrick JR. The significance of hypoalbuminemia following injury and infection. Am Surg 1985; 51: 340-3.
19. Roy S, Sen CK, Kobuchi H, Packer L. Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells. Free Radic Biol Med 1998; 25: 229-41.
20. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: S27-72.
21. Zilberberg MD, Shorr AF. Epidemiology of healthcare-associated pneumonia (HCAP). Semin Respir Crit Care Med 2009; 30: 10-5.
22. Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D'Agata EM. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008; 56: 1276-80.
23. Pop-Vicas A, Strom J, Stanley K, D'Agata EM. Multidrug-resistant gramnegative bacteria among patients who require chronic hemodialysis. Clin J Am Soc Nephrol 2008; 3: 752-8.
24. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-23.
25. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32: 1162-71.
26. Szilágyi E, Füzi M, Böröcz K, Kurcz A, Tóth A, Nagy K. Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae; findings of the nosocomial surveillance system in Hungary. Acta Microbiol Immunol Hung 2009; 56: 251-62.
27. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health careassociated pneumonia. Arch Intern Med 2008; 168: 2205-10.
28. Center for Disease Control and Prevention. Dialysis safety Guidelines and recommendations. Available athttp://www.cdc.gov/dialysis/guidelines/index.html [accessed on 9 March 2013].
29. Wilson AP, Ridgway GL. Reducing hospital-acquired infection by design: the new University College London Hospital. J Hosp Infect 2006; 62: 264-9.